PMCF Study of Precise Pro Rx for Carotid Artery Disease

Not yet recruitingOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions
Carotid Artery Stenosis
Interventions
DEVICE

PRECISE PRO Rx Nitinol Stent System

The Cordis PRECISE PRO Rx Nitinol Stent System is a single-use device consisting of an endovascular stent and sheath delivery system, intended to deliver a self-expanding endovascular stent to the carotid artery(ies). The stent component imparts an outward radial force on the luminal surface of the vessel wall restoring vascular patency. The Cordis PRECISE PRO Rx Nitinol Stent System is indicated for use in patients with stenotic lesions of the carotid artery(ies).

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Rede Optimus Hospitalar SA

NETWORK

lead

Cordis Corporation

INDUSTRY

NCT07204678 - PMCF Study of Precise Pro Rx for Carotid Artery Disease | Biotech Hunter | Biotech Hunter